orbimed
OrbiMed Invests US$551 Million In Asian Healthcare
The leading healthcare investment firm will use the US$551 million raised to support growth-stage product- and services-oriented companies in China and India.
The leading healthcare investment firm will use the US$551 million raised to support growth-stage product- and services-oriented companies in China and India.